Efficacy and safety of finerenone in non-diabetic patients with IgA nephropathy

Finerenone is safe and effective in treating IgAN patients without diabetes, and finerenone combined with SGLT2i has a higher CR rate.

Authors

Institutions

Publication Details

Journal
Nephrology Dialysis Transplantation
Published
2026-02-05
DOI
https://doi.org/10.1093/ndt/gfag023
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of finerenone in non-diabetic patients with IgA nephropathy

Zhaochen Guo, J. X. Chen, Bian Wu, Zige Chen et al.
Nephrology Dialysis Transplantation
Renal Diseases and Glomerulopathies
article

Efficacy and safety of finerenone in non-diabetic patients with IgA nephropathy

Zhaochen Guo, J. X. Chen, Bian Wu, Zige Chen, Hao Bao, Ju’An Wang, Zhihong Liu, Yuanmao Tu
article en

Abstract

Finerenone is safe and effective in treating IgAN patients without diabetes, and finerenone combined with SGLT2i has a higher CR rate.

Nephrology Dialysis Transplantation
Nanjing General Hospital of Nanjing Military Command (CN), National Clinical Research (US), Nanjing University (CN)
Good health and well-being
Openalex Percentile: Top 68%
Renal Diseases and Glomerulopathies
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.